Design, Synthesis, and Biological Evaluation of C-2 Substituted 3Hthieno[ 2,3-d]pyrimidin-4-one Derivatives as Novel FGFR1 Inhibitors
作者:Ping Guo、Zixin Xie、Huan Zhang、Zaikui Zhang、Chao Han、Donghua Cheng、Dan Lin、Yuan Zhang、Xuebao Wang、Xin Guo、Faqing Ye
DOI:10.2174/1573406413666170623084525
日期:2017.11.8
compound thienopyrimidinone. Methods: In the present study, a series of C-2 substituted derivatives of thienopyrimidinone, namely L1–L16, were synthesized, and their inhibitory effects on FGFR1 were evaluated. The anti-proliferative activities of these compounds were assessed by MTT assay. Results: Among the novel derivatives, L11 was found to exert remarkable FGFR1 inhibitory activity (79.93% at 10 µM) and
背景:噻吩并嘧啶酮是一种新设计的选择性成纤维细胞生长因子受体1(FGFR1)抑制剂,具有出色的抗癌作用。 目的:本研究的目的是通过修饰先导化合物噻吩并嘧啶酮来设计和合成更好的FGFR1抑制剂。 方法:本研究合成了一系列噻吩并嘧啶酮的C-2取代衍生物,即L1-L16,并评价了它们对FGFR1的抑制作用。这些化合物的抗增殖活性通过MTT分析评估。 结果:在新的衍生物中,发现L11具有显着的FGFR1抑制活性(在10 µM时为79.93%)和抗增殖活性,在过表达FGFR1的细胞系H460中IC50值为2.1、2.5和3.5 µM ,HT-1197和B16F10。 结论:我们新合成的噻吩并嘧啶酮衍生物可能是潜在的FGFR1抑制剂,有望作为新型抗癌药开发。